Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3Hypertension, Portal 2Liver Diseases 1Liver Cirrhosis 1Hepatocellular Carcinoma with PVTT 1Gastrointestinal Neoplasms 1Ascites 1

Interventions

Sorafenib 5lenvatinib 3sintilimab 2pembrolizumab 2halofantrine 2camrelizumab 2atezolizumab 2Immunotherapy 2Blood Specimen Collection 2Bevacizumab 2Antibodies 2trifluridine tipiracil drug combination 1trametinib 1toripalimab 1titanium silicide 1tislelizumab 1linifanib 1genexol-PM 1gadolinium ethoxybenzyl DTPA 1fluorocholine 1fisogatinib 1ficlatuzumab 1durvalumab 1bavituximab 1avelumab 1User-Centered Design 1Sunitinib 1Sufentanil 1Standard of Care 1Shadowing Technique, Histology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × Portasystemic Shunt, Transjugular Intrahepatic × Gastrointestinal × Clear all
NCT04640116 2020-12-19

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Sun Yat-sen University

Phase NA Unknown
30 enrolled
Gastrointestinal

Ascites, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡